J Jassem
Impact in
-
- Menopause: Health Impacts and Treatments
-
- Cancer Risks and Factors
- Cancer survivorship and care
Papers in
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Occupational and environmental lung diseases 2
- Pleural and Pulmonary Diseases 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 3
- Lung Cancer Research Studies 2
- Co-authors
- R. Arriagada (1 shared paper)Marit Holmqvist (1 shared paper)O Peralta (1 shared paper)Lars Holmberg (1 shared paper)Janusz Jaśkiewicz (1 shared paper)Mats Hammar (1 shared paper)Ole Erik Iversen (1 shared paper)E. Kumpulainen (1 shared paper)
In The Last Decade
J Jassem
21 papers receiving 296 citations
Peers
Comparison fields: 5 of 45
- Endocrinology, Diabetes and Metabolism 115
- Oncology 115
- Obstetrics and Gynecology 31
- Genetics 96
- Reproductive Medicine 22
Countries citing papers authored by J Jassem
This map shows the geographic impact of J Jassem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Jassem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Jassem more than expected).
Fields of papers citing papers by J Jassem
This network shows the impact of papers produced by J Jassem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Jassem. The network helps show where J Jassem may publish in the future.
Co-authors
The 25 scholars most cited alongside J Jassem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 216 | |
| 2 | 1996 | 14 | |
| 3 | 2003 | 13 | |
| 4 | Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)--a preliminary report. | 2001 | 12 |
| 5 | 2009 | 11 | |
| 6 | 2006 | 7 | |
| 7 | Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). | 1990 | 7 |
| 8 | 2003 | 7 | |
| 9 | The incidence of chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients | 2007 | 5 |
| 10 | 2006 | 5 | |
| 11 | The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease. | 1999 | 4 |
| 12 | 2007 | 3 | |
| 13 | GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) | 2008 | 2 |
| 14 | 2001 | 2 | |
| 15 | [Autoantibodies in patients with malignant tumors]. | 1980 | 2 |
| 16 | [Analysis of prognostic factors for long term survival in patients with small cell lung cancer]. | 1994 | 2 |
| 17 | [Platinum-based chemotherapy in renal transplant recipients with malignancies: a case report and review of literature]. | 1998 | 1 |
| 18 | 2015 | 1 | |
| 19 | [Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer]. | 1998 | 1 |
| 20 | 2010 | 1 |
About J Jassem
J Jassem is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 22 papers that have together received 317 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Peptidase Inhibition and Analysis (3 papers), Lung Cancer Treatments and Mutations (3 papers), Occupational and environmental lung diseases (2 papers), Lung Cancer Research Studies (2 papers), Pleural and Pulmonary Diseases (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (115 citations), Oncology (115 citations), Obstetrics and Gynecology (31 citations), Genetics (96 citations) and Reproductive Medicine (22 citations). J Jassem has collaborated with scholars based in Poland, Sweden and Hungary. Frequent co-authors include R. Arriagada, Marit Holmqvist, O Peralta, Lars Holmberg, Janusz Jaśkiewicz, Mats Hammar, Ole Erik Iversen, E. Kumpulainen, Hans E. Fjøsne and C.-M. Rudenstam. Their work appears in journals such as European Journal of Cancer, Lung Cancer, Journal of Clinical Oncology, Annals of Oncology and Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.